Drug shortages

Dexamethasone Sodium Phosphate Injection

Eugia US LLC · Unavailable · Reason: Demand increase for the drug

Current55150-304-25Dermatology +9
Open FDA's page for this record
Update type
Revised
Initial posting date
02/08/2019
Package NDC
55150-304-25
Generic name
Dexamethasone Sodium Phosphate Injection
Contact info
888-238-7880
Availability
Unavailable
Related info
On backorder. Recovery: TBD. Check wholesalers for inventory
Update date
11/19/2026
Dosage form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)
Company name
Eugia US LLC
Shortage reason
Demand increase for the drug
Status
Current
Therapeutic category
Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology
Harmonized identifiers (openFDA)
Application number
ANDA210966
Brand name
DEXAMETHASONE SODIUM PHOSPHATE
Generic name
DEXAMETHASONE SODIUM PHOSPHATE
Manufacturer name
Eugia US LLC
Product NDC
55150-304
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAMUSCULAR, INTRAVENOUS
Substance name
DEXAMETHASONE SODIUM PHOSPHATE
RxCUI
1812079
SPL ID
5d97a8a3-fd79-4fd1-8a0f-c8cf95d40964
SPL set ID
29947f67-7868-40af-8ad2-a61f7149b44c
Package NDC
55150-304-01, 55150-304-25
UNII
AI9376Y64P
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.